Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Tscan Therapeutics Inc (TCRX)

Tscan Therapeutics Inc (TCRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Tscan Therapeutics Inc 830 WINTER STREET WALTHAM MA 02451 USA

www.tscan.com Employees: 194 P: 857-399-9500

Sector:

Medical

Description:

TScan Therapeutics Inc. is a biopharmaceutical company. It focused on the development of T-cell receptor engineered T cell therapies for the treatment of patients with cancer. The company's lead product pipeline consist TSC-100 and TSC-101. TScan Therapeutics Inc. is based in WALTHAM, Mass.

Key Statistics

Overview:

Market Capitalization, $K 57,315
Enterprise Value, $K -89,305
Shares Outstanding, K 56,748
Float, K 54,279
% Float 95.65%
Short Interest, K 2,566
Short Float 4.52%
Days to Cover 5.29
Short Volume Ratio 0.21
% of Insider Shareholders 4.35%
% of Institutional Shareholders 82.83%

Financials:

Annual Sales, $ 2,820 K
Annual Net Income, $ -127,500 K
Last Quarter Sales, $ 2,510 K
Last Quarter Net Income, $ -35,710 K
EBIT, $ -148,660 K
EBITDA, $ -144,550 K

Growth:

1-Year Return -53.88%
3-Year Return -66.22%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.28 on 11/12/25
Next Earnings Date 03/04/26 [--]
Earnings Per Share ttm -1.11
EPS Growth vs. Prev Qtr 0.00%
EPS Growth vs. Prev Year -12.00%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

TCRX Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -73.33%
Return-on-Assets % -44.76%
Profit Margin % -4,521.28%
Debt/Equity 0.23
Price/Sales 15.29
Price/Cash Flow N/A
Price/Book 0.40
Book Value/Share 2.54
Interest Coverage -33.93
60-Month Beta 1.04
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar